"country","code","population_size","world_bank_economies","date_tests_last_reported","days_since_tests_reported","tpr_year_smoothed_truncated","avg_daily_tests_per_1000_last_year_smoothed","cum_seq","pct_cases_sequenced_in_last_year","sequences_per_100k_last_year","dx_testing_binary","sars_cov_2_binary","ngs_capacity","facility_access","ngs_facility","archetype_orig","dx_archetype","sx_archetype","dx_testing_rec","sx_sequencing_rec","prev_dx","prev_sequ","seq_but_no_test_flag","TPR_pct","daily_tests_per_1000","pct_seq","seq_per_100k"
"Afghanistan","AFG",38928000,"Low income","May 12, 2022",173,0.13,0.02,120,0.04,0.041,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","13 %","0.02 per 1,000 persons","0.04 %","0 per 100k persons"
"Albania","ALB",2878000,"Upper middle income","October 30, 2022",2,0.2135,0.66,58,0.01,0.528,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","21.3 %","0.66 per 1,000 persons","0.01 %","0.5 per 100k persons"
"Algeria","DZA",43851000,"Lower middle income","November 01, 2020",730,NaN,NaN,472,0.48,0.688,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.48 %","0.7 per 100k persons"
"American Samoa","ASM",NaN,"Upper middle income","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Andorra","AND",77000,"High income","March 01, 2022",245,0.2869,8.34,347,1,388.262,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","28.7 %","8.34 per 1,000 persons","1 %","388.3 per 100k persons"
"Angola","AGO",32866000,"Lower middle income","September 13, 2022",49,0.0209,0.18,1283,0.31,0.332,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","2.1 %","0.18 per 1,000 persons","0.31 %","0.3 per 100k persons"
"Anguilla","AIA",NaN,"No income data","No tests reported",NaN,NaN,NaN,101,2.22,409.397,"Insufficient testing data","Meets sequencing target",NaN,"Insufficient data",NaN,"Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","2.22 %","409.4 per 100k persons"
"Antigua and Barbuda","ATG",98000,"High income","June 07, 2021",512,NaN,NaN,239,2.06,110.907,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","2.06 %","110.9 per 100k persons"
"Argentina","ARG",45196000,"Upper middle income","April 17, 2022",198,0.3532,1.39,21814,0.19,18.877,"Insufficient testing data","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","35.3 %","1.39 per 1,000 persons","0.19 %","18.9 per 100k persons"
"Armenia","ARM",2963000,"Upper middle income","June 06, 2022",148,0.1035,1.76,192,0.03,1.439,"Meets testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Sustain","Connect/Build","Sustain - Sustain diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Sustain","Connect/Build","no","10.3 %","1.76 per 1,000 persons","0.03 %","1.4 per 100k persons"
"Aruba","ABW",NaN,"High income","No tests reported",NaN,NaN,NaN,3716,3.12,828.488,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","3.12 %","828.5 per 100k persons"
"Australia","AUS",25500000,"High income","September 09, 2022",53,0.2827,4.42,160287,1.13,442.374,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","28.3 %","4.42 per 1,000 persons","1.13 %","442.4 per 100k persons"
"Austria","AUT",9006000,"High income","October 29, 2022",3,0.0448,31.51,176483,2.56,1325.448,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","4.5 %","31.51 per 1,000 persons","2.56 %","1325.4 per 100k persons"
"Azerbaijan","AZE",10139000,"Upper middle income","October 31, 2022",1,0.138,0.58,151,0,0.116,"Meets testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","13.8 %","0.58 per 1,000 persons","0 %","0.1 per 100k persons"
"Bahrain","BHR",1702000,"High income","November 01, 2022",0,0.1144,5.81,10302,1.86,520.908,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","11.4 %","5.81 per 1,000 persons","1.86 %","520.9 per 100k persons"
"Bangladesh","BGD",164689000,"Lower middle income","October 30, 2022",2,0.0987,0.08,7291,0.54,1.468,"Does not meet testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","9.9 %","0.08 per 1,000 persons","0.54 %","1.5 per 100k persons"
"Barbados","BRB",287000,"High income","October 14, 2022",18,0.2233,3.82,222,0.15,45.447,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","22.3 %","3.82 per 1,000 persons","0.15 %","45.4 per 100k persons"
"Belarus","BLR",9449000,"Upper middle income","July 06, 2022",118,0.0963,1.73,520,0.06,2.643,"Meets testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","9.6 %","1.73 per 1,000 persons","0.06 %","2.6 per 100k persons"
"Belgium","BEL",11590000,"High income","October 28, 2022",4,0.2273,3.4,165601,3.04,847.629,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","22.7 %","3.4 per 1,000 persons","3.04 %","847.6 per 100k persons"
"Belize","BLZ",398000,"Upper middle income","June 10, 2022",144,0.1273,3,1030,1.59,164.329,"Meets testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","12.7 %","3 per 1,000 persons","1.59 %","164.3 per 100k persons"
"Benin","BEN",12123000,"Lower middle income","January 25, 2022",280,NaN,NaN,1250,15.53,3.527,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","15.53 %","3.5 per 100k persons"
"Bermuda","BMU",62000,"High income","October 20, 2022",12,0,19.11,233,1.28,252.309,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","No cases reported","19.11 per 1,000 persons","1.28 %","252.3 per 100k persons"
"Bhutan","BTN",772000,"Lower middle income","March 01, 2022",245,0.0191,5.75,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","1.9 %","5.75 per 1,000 persons","0 %","0 per 100k persons"
"Bolivia","BOL",11673000,"Lower middle income","January 02, 2022",303,0.2184,0.6,345,0.02,0.744,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","21.8 %","0.6 per 1,000 persons","0.02 %","0.7 per 100k persons"
"Bosnia and Herzegovina","BIH",3281000,"Upper middle income","October 31, 2022",1,0.3457,0.36,1456,0.6,27.184,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","34.6 %","0.36 per 1,000 persons","0.6 %","27.2 per 100k persons"
"Botswana","BWA",2352000,"Upper middle income","May 18, 2022",167,0.2564,0.99,4575,2.1,110.938,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","25.6 %","0.99 per 1,000 persons","2.1 %","110.9 per 100k persons"
"Brazil","BRA",212559000,"Upper middle income","August 17, 2022",76,0.8,0.25,187199,0.67,40.729,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","80 %","0.25 per 1,000 persons","0.67 %","40.7 per 100k persons"
"British Indian Ocean Territory","IOT",NaN,"No income data","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"British Virgin Islands","VGB",NaN,"High income","No tests reported",NaN,NaN,NaN,195,2.18,319.163,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","2.18 %","319.2 per 100k persons"
"Brunei","BRN",437000,"High income","December 14, 2021",322,0.0145,8.5,3988,1.75,876.165,"Insufficient testing data","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","1.5 %","8.5 per 1,000 persons","1.75 %","876.2 per 100k persons"
"Bulgaria","BGR",6948000,"Upper middle income","November 01, 2022",0,0.1303,2.06,20208,1.57,154.896,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","13 %","2.06 per 1,000 persons","1.57 %","154.9 per 100k persons"
"Burkina Faso","BFA",20903000,"Low income","March 09, 2022",237,0.0893,0.02,664,0.32,0.097,"Insufficient testing data","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","8.9 %","0.02 per 1,000 persons","0.32 %","0.1 per 100k persons"
"Burundi","BDI",11891000,"Low income","October 18, 2022",14,0.0287,0.25,157,0.31,0.729,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","2.9 %","0.25 per 1,000 persons","0.31 %","0.7 per 100k persons"
"Cambodia","KHM",16719000,"Lower middle income","October 24, 2022",8,0.0404,0.08,3654,11.2,12.941,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","4 %","0.08 per 1,000 persons","11.2 %","12.9 per 100k persons"
"Cameroon","CMR",26546000,"Lower middle income","August 25, 2022",68,0.0158,0.15,1305,2.93,2.221,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","1.6 %","0.15 per 1,000 persons","2.93 %","2.2 per 100k persons"
"Canada","CAN",37742000,"High income","October 28, 2022",4,0.1349,1.45,413566,8.59,594.635,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","13.5 %","1.45 per 1,000 persons","8.59 %","594.6 per 100k persons"
"Cape Verde","CPV",556000,"Lower middle income","October 18, 2022",14,0.1317,0.93,694,1.84,74.853,"Meets testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","13.2 %","0.93 per 1,000 persons","1.84 %","74.9 per 100k persons"
"Cayman Islands","CYM",NaN,"High income","No tests reported",NaN,NaN,NaN,101,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Central African Republic","CAF",4830000,"Low income","October 31, 2022",1,0.0923,0.02,110,1.28,0.842,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","9.2 %","0.02 per 1,000 persons","1.28 %","0.8 per 100k persons"
"Chad","TCD",16426000,"Low income","October 31, 2022",1,0.0473,0.01,49,1.35,0.192,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","4.7 %","0.01 per 1,000 persons","1.35 %","0.2 per 100k persons"
"Chile","CHL",19116000,"High income","October 31, 2022",1,0.135,3.25,37023,0.68,106.327,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","13.5 %","3.25 per 1,000 persons","0.68 %","106.3 per 100k persons"
"China","CHN",1439324000,"Upper middle income","June 24, 2020",860,NaN,NaN,2493,0.08,0.053,"Insufficient testing data","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","Insufficient data","Insufficient data","0.08 %","0.1 per 100k persons"
"Colombia","COL",50883000,"Upper middle income","October 27, 2022",5,0.1308,0.54,23247,0.94,23.536,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","13.1 %","0.54 per 1,000 persons","0.94 %","23.5 per 100k persons"
"Comoros","COM",870000,"Lower middle income","July 06, 2022",118,0.0907,0.2,46,0.62,3.346,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","9.1 %","0.2 per 1,000 persons","0.62 %","3.3 per 100k persons"
"Cook Islands","COK",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",NaN,"Insufficient data",NaN,"Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Costa Rica","CRI",5094000,"Upper middle income","June 01, 2022",153,0.1619,1.92,7517,0.99,108.921,"Meets testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","16.2 %","1.92 per 1,000 persons","0.99 %","108.9 per 100k persons"
"Croatia","HRV",4105000,"High income","October 30, 2022",2,0.3545,1.48,38648,3.54,681.056,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","35.4 %","1.48 per 1,000 persons","3.54 %","681.1 per 100k persons"
"Cuba","CUB",11327000,"Upper middle income","October 17, 2022",15,0.0437,0.92,1600,0.34,4.754,"Meets testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Sustain","Connect/Build","Sustain - Sustain diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Sustain","Connect/Build","no","4.4 %","0.92 per 1,000 persons","0.34 %","4.8 per 100k persons"
"Cura√ßao","CUW",NaN,"High income","No tests reported",NaN,NaN,NaN,2086,4.09,607.303,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","4.09 %","607.3 per 100k persons"
"Cyprus","CYP",1207000,"High income","July 11, 2021",478,NaN,NaN,1372,0.14,71.651,"Insufficient testing data","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","Insufficient data","Insufficient data","0.14 %","71.7 per 100k persons"
"Czech Republic","CZE",10709000,"High income","November 01, 2022",0,0.15,4.12,53504,1.54,351.468,"Meets testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","15 %","4.12 per 1,000 persons","1.54 %","351.5 per 100k persons"
"Democratic Republic of the Congo","COD",89561000,"Low income","October 31, 2022",1,0.0484,0.02,1303,0.73,0.264,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","4.8 %","0.02 per 1,000 persons","0.73 %","0.3 per 100k persons"
"Denmark","DNK",5792000,"High income","October 28, 2022",4,0.0752,18.86,591504,13.32,6667.132,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","7.5 %","18.86 per 1,000 persons","13.32 %","6667.1 per 100k persons"
"Djibouti","DJI",988000,"Lower middle income","September 20, 2022",42,0.0189,0.37,832,20.7,40.773,"Does not meet testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","1.9 %","0.37 per 1,000 persons","20.7 %","40.8 per 100k persons"
"Dominica","DMA",72000,"Upper middle income","December 28, 2021",308,0.06,7.4,39,0.18,27.488,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","6 %","7.4 per 1,000 persons","0.18 %","27.5 per 100k persons"
"Dominican Republic","DOM",10848000,"Upper middle income","October 14, 2022",18,0.1826,0.38,1889,0.39,9.271,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","18.3 %","0.38 per 1,000 persons","0.39 %","9.3 per 100k persons"
"East Timor","TLS",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,357,0.03,0.075,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.03 %","0.1 per 100k persons"
"Ecuador","ECU",17643000,"Upper middle income","February 01, 2022",273,0.4112,0.33,7925,0.87,23.804,"Insufficient testing data","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","41.1 %","0.33 per 1,000 persons","0.87 %","23.8 per 100k persons"
"Egypt","EGY",102334000,"Lower middle income","August 15, 2022",78,0.024,0.26,2884,0.8,1.331,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","2.4 %","0.26 per 1,000 persons","0.8 %","1.3 per 100k persons"
"El Salvador","SLV",6486000,"Lower middle income","August 30, 2022",63,0.0671,0.63,611,0.42,5.871,"Meets testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","6.7 %","0.63 per 1,000 persons","0.42 %","5.9 per 100k persons"
"Equatorial Guinea","GNQ",1403000,"Upper middle income","October 31, 2022",1,0.0263,0.29,214,0.15,0.358,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","2.6 %","0.29 per 1,000 persons","0.15 %","0.4 per 100k persons"
"Eritrea","ERI",3546000,"Low income","December 21, 2020",680,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Estonia","EST",1327000,"High income","October 25, 2022",7,0.2916,2.98,14550,1.75,543.337,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","29.2 %","2.98 per 1,000 persons","1.75 %","543.3 per 100k persons"
"Eswatini","SWZ",1160000,"Lower middle income","October 31, 2022",1,0.1507,0.43,1054,2.01,45.353,"Does not meet testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","15.1 %","0.43 per 1,000 persons","2.01 %","45.4 per 100k persons"
"Ethiopia","ETH",114964000,"Low income","October 31, 2022",1,0.0794,0.04,616,0.07,0.075,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","7.9 %","0.04 per 1,000 persons","0.07 %","0.1 per 100k persons"
"Falkland Islands","FLK",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",NaN,"Insufficient data",NaN,"Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Faroe Islands","FRO",49000,"High income","February 27, 2022",247,0,50.69,42,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","No cases reported","50.69 per 1,000 persons","0 %","0 per 100k persons"
"Fiji","FJI",896000,"Upper middle income","October 27, 2022",5,0.0701,0.71,531,0,0,"Meets testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Sustain","Connect/Build","Sustain - Sustain diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Sustain","Connect/Build","no","7 %","0.71 per 1,000 persons","0 %","0 per 100k persons"
"Finland","FIN",5541000,"High income","October 27, 2022",5,0.2852,2.06,38832,1.36,291.098,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","28.5 %","2.06 per 1,000 persons","1.36 %","291.1 per 100k persons"
"France","FRA",65274000,"High income","May 17, 2022",168,0.1871,9.08,505360,1.19,523.227,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","18.7 %","9.08 per 1,000 persons","1.19 %","523.2 per 100k persons"
"French Polynesia","PYF",281000,"High income","September 07, 2020",785,NaN,NaN,110,0.07,6.856,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.07 %","6.9 per 100k persons"
"French Southern and Antarctic Lands","ATF",NaN,"No income data","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Gabon","GAB",2226000,"Upper middle income","October 31, 2022",1,0.045,0.37,967,0.55,3.098,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","4.5 %","0.37 per 1,000 persons","0.55 %","3.1 per 100k persons"
"Georgia","GEO",3989000,"Upper middle income","June 16, 2021",503,NaN,NaN,2389,0.17,49.007,"Insufficient testing data","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","Insufficient data","Insufficient data","0.17 %","49 per 100k persons"
"Germany","DEU",83784000,"High income","October 20, 2022",12,0.4672,2.21,813496,1.8,669.892,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","46.7 %","2.21 per 1,000 persons","1.8 %","669.9 per 100k persons"
"Ghana","GHA",31073000,"Lower middle income","October 31, 2022",1,0.0619,0.06,4221,3.57,4.337,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","6.2 %","0.06 per 1,000 persons","3.57 %","4.3 per 100k persons"
"Gibraltar","GIB",NaN,"High income","No tests reported",NaN,NaN,NaN,2749,7.44,3219.39,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","7.44 %","3219.4 per 100k persons"
"Greece","GRC",10423000,"High income","October 25, 2022",7,0.0614,18.94,22139,0.26,108.031,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","6.1 %","18.94 per 1,000 persons","0.26 %","108 per 100k persons"
"Greenland","GRL",57000,"High income","August 31, 2022",62,0,5.75,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","No cases reported","5.75 per 1,000 persons","0 %","0 per 100k persons"
"Grenada","GRD",113000,"Upper middle income","September 23, 2022",39,0.132,2.8,58,0.01,0.797,"Meets testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Sustain","Connect/Build","Sustain - Sustain diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Sustain","Connect/Build","no","13.2 %","2.8 per 1,000 persons","0.01 %","0.8 per 100k persons"
"Guam","GUM",NaN,"High income","No tests reported",NaN,NaN,NaN,923,NaN,NaN,"Insufficient testing data","Insufficient data",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Guatemala","GTM",17916000,"Upper middle income","November 01, 2022",0,0.1679,0.49,2634,0.22,6.792,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","16.8 %","0.49 per 1,000 persons","0.22 %","6.8 per 100k persons"
"Guernsey","GGY",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Guinea","GIN",13133000,"Low income","October 31, 2022",1,0.0461,0.03,826,5.16,2.749,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","4.6 %","0.03 per 1,000 persons","5.16 %","2.7 per 100k persons"
"Guinea-Bissau","GNB",1968000,"Low income","July 11, 2022",113,0.0526,0.09,49,0.04,0.047,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","5.3 %","0.09 per 1,000 persons","0.04 %","0 per 100k persons"
"Guyana","GUY",787000,"Upper middle income","December 28, 2021",308,0.0502,1.61,145,0.23,10.016,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","5 %","1.61 per 1,000 persons","0.23 %","10 per 100k persons"
"Haiti","HTI",NaN,"Low income","No tests reported",NaN,NaN,NaN,442,0.87,0.734,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.87 %","0.7 per 100k persons"
"Heard Island and McDonald Islands","HMD",NaN,"No income data","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Honduras","HND",9905000,"Lower middle income","October 18, 2022",14,0.1763,0.13,233,0.08,0.604,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","17.6 %","0.13 per 1,000 persons","0.08 %","0.6 per 100k persons"
"Hong Kong SAR, China","HKG",7497000,"High income","October 16, 2022",16,0,15.24,10220,0.37,93.993,"Insufficient testing data","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","No cases reported","15.24 per 1,000 persons","0.37 %","94 per 100k persons"
"Hungary","HUN",9660000,"High income","May 11, 2022",174,0.26,2.15,557,0.01,1.214,"Does not meet testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","26 %","2.15 per 1,000 persons","0.01 %","1.2 per 100k persons"
"Iceland","ISL",341000,"High income","August 23, 2022",70,0.2059,9.13,11641,0.95,490.476,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","yes","20.6 %","9.13 per 1,000 persons","0.95 %","490.5 per 100k persons"
"India","IND",1380004000,"Lower middle income","October 31, 2022",1,0.0352,0.59,227020,1.15,8.409,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","3.5 %","0.59 per 1,000 persons","1.15 %","8.4 per 100k persons"
"Indonesia","IDN",273524000,"Upper middle income","October 31, 2022",1,0.035,0.64,38270,1.2,9.763,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","3.5 %","0.64 per 1,000 persons","1.2 %","9.8 per 100k persons"
"Iran","IRN",83993000,"Upper middle income","September 20, 2022",42,0.0875,0.68,2649,0.12,2.213,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","8.8 %","0.68 per 1,000 persons","0.12 %","2.2 per 100k persons"
"Iraq","IRQ",40223000,"Upper middle income","August 06, 2022",87,0.1193,0.29,1273,0.15,1.387,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","11.9 %","0.29 per 1,000 persons","0.15 %","1.4 per 100k persons"
"Ireland","IRL",4938000,"High income","October 28, 2022",4,0.2641,2.62,93487,3.95,966.155,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","26.4 %","2.62 per 1,000 persons","3.95 %","966.2 per 100k persons"
"Isle of Man","IMN",NaN,"High income","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Israel","ISR",8656000,"High income","January 23, 2022",282,0.0648,20.59,138012,3.31,1176.347,"Insufficient testing data","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","6.5 %","20.59 per 1,000 persons","3.31 %","1176.3 per 100k persons"
"Italy","ITA",60462000,"High income","October 29, 2022",3,0.1255,6.77,152160,0.41,130.766,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","12.6 %","6.77 per 1,000 persons","0.41 %","130.8 per 100k persons"
"Ivory Coast","CIV",26378000,"Lower middle income","October 31, 2022",1,0.0475,0.06,775,0.32,0.305,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","4.8 %","0.06 per 1,000 persons","0.32 %","0.3 per 100k persons"
"Jamaica","JAM",2961000,"Upper middle income","September 30, 2022",32,0.1144,0.55,2460,3.07,68.296,"Meets testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","11.4 %","0.55 per 1,000 persons","3.07 %","68.3 per 100k persons"
"Japan","JPN",126476000,"High income","October 31, 2022",1,0.3934,1.13,449213,1.28,212.05,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","39.3 %","1.13 per 1,000 persons","1.28 %","212.1 per 100k persons"
"Jersey","JEY",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Jordan","JOR",10203000,"Upper middle income","July 27, 2022",97,0.1497,2.05,1497,0.04,2.853,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","15 %","2.05 per 1,000 persons","0.04 %","2.9 per 100k persons"
"Kazakhstan","KAZ",18777000,"Upper middle income","May 28, 2021",522,NaN,NaN,1422,0.17,4.083,"Insufficient testing data","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","Insufficient data","Insufficient data","0.17 %","4.1 per 100k persons"
"Kenya","KEN",53771000,"Lower middle income","October 31, 2022",1,0.0705,0.06,11479,5.35,8.498,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","7 %","0.06 per 1,000 persons","5.35 %","8.5 per 100k persons"
"Kiribati","KIR",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,137,3.96,103.629,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","3.96 %","103.6 per 100k persons"
"Kosovo","XKX",NaN,"Upper middle income","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Kuwait","KWT",4271000,"High income","March 10, 2022",236,0.0713,5.27,810,0.17,10.213,"Insufficient testing data","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","7.1 %","5.27 per 1,000 persons","0.17 %","10.2 per 100k persons"
"Kyrgyzstan","KGZ",6524000,"Lower middle income","June 23, 2021",496,NaN,NaN,326,0.34,1.297,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.34 %","1.3 per 100k persons"
"Laos","LAO",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,477,0.26,6.096,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.26 %","6.1 per 100k persons"
"Latvia","LVA",1886000,"High income","October 31, 2022",1,0.258,4.15,17769,1.1,435.468,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","25.8 %","4.15 per 1,000 persons","1.1 %","435.5 per 100k persons"
"Lebanon","LBN",6825000,"Upper middle income","June 23, 2021",496,NaN,NaN,2438,0.1,10.201,"Insufficient testing data","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","Insufficient data","Insufficient data","0.1 %","10.2 per 100k persons"
"Lesotho","LSO",2142000,"Lower middle income","October 31, 2022",1,0.0509,0.32,252,0.93,5.161,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","5.1 %","0.32 per 1,000 persons","0.93 %","5.2 per 100k persons"
"Liberia","LBR",5058000,"Low income","September 26, 2021",401,NaN,NaN,110,1.51,0.622,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","1.51 %","0.6 per 100k persons"
"Libya","LBY",6871000,"Upper middle income","October 31, 2022",1,0.176,0.65,84,0.02,0.514,"Meets testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Sustain","Connect/Build","Sustain - Sustain diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Sustain","Connect/Build","no","17.6 %","0.65 per 1,000 persons","0.02 %","0.5 per 100k persons"
"Liechtenstein","LIE",NaN,"High income","No tests reported",NaN,NaN,NaN,1706,9.36,4032.524,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","9.36 %","4032.5 per 100k persons"
"Lithuania","LTU",2722000,"High income","October 31, 2022",1,0.2778,3.13,40226,1.89,586.933,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","27.8 %","3.13 per 1,000 persons","1.89 %","586.9 per 100k persons"
"Luxembourg","LUX",626000,"High income","October 20, 2022",12,0.255,3.83,48406,14.32,4875.07,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","25.5 %","3.83 per 1,000 persons","14.32 %","4875.1 per 100k persons"
"Macao SAR, China","MAC",NaN,"High income","No tests reported",NaN,NaN,NaN,1,0.14,0.144,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.14 %","0.1 per 100k persons"
"Madagascar","MDG",27691000,"Low income","October 07, 2022",25,0.0913,0.03,879,0.35,0.274,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","9.1 %","0.03 per 1,000 persons","0.35 %","0.3 per 100k persons"
"Malawi","MWI",19130000,"Low income","October 31, 2022",1,0.1345,0.03,1250,0.86,1.103,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","13.5 %","0.03 per 1,000 persons","0.86 %","1.1 per 100k persons"
"Malaysia","MYS",32366000,"Upper middle income","June 16, 2021",503,NaN,NaN,30106,0.96,68.292,"Insufficient testing data","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","0.96 %","68.3 per 100k persons"
"Maldives","MDV",541000,"Upper middle income","November 09, 2021",357,0.0339,7.88,1294,0.72,134.785,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","3.4 %","7.88 per 1,000 persons","0.72 %","134.8 per 100k persons"
"Mali","MLI",20251000,"Low income","October 31, 2022",1,0.0491,0.05,202,0.63,0.46,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","4.9 %","0.05 per 1,000 persons","0.63 %","0.5 per 100k persons"
"Malta","MLT",442000,"High income","September 06, 2021",421,NaN,NaN,893,0.64,92.632,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","0.64 %","92.6 per 100k persons"
"Marshall Islands","MHL",NaN,"Upper middle income","No tests reported",NaN,NaN,NaN,23,0.15,55.298,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.15 %","55.3 per 100k persons"
"Mauritania","MRT",4650000,"Lower middle income","October 31, 2022",1,0.0501,0.31,58,0.03,0.169,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","5 %","0.31 per 1,000 persons","0.03 %","0.2 per 100k persons"
"Mauritius","MUS",1272000,"High income","June 20, 2022",134,0.2877,2.43,4615,1.62,301.89,"Does not meet testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","28.8 %","2.43 per 1,000 persons","1.62 %","301.9 per 100k persons"
"Mexico","MEX",128933000,"Upper middle income","October 30, 2022",2,0.4541,0.16,78478,1.14,29.619,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","45.4 %","0.16 per 1,000 persons","1.14 %","29.6 per 100k persons"
"Micronesia","FSM",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Moldova","MDA",4034000,"Lower middle income","June 13, 2021",506,NaN,NaN,657,0.21,16.621,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.21 %","16.6 per 100k persons"
"Monaco","MCO",NaN,"High income","No tests reported",NaN,NaN,NaN,101,0.17,54.808,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.17 %","54.8 per 100k persons"
"Mongolia","MNG",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,1490,0.16,18.009,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.16 %","18 per 100k persons"
"Montenegro","MNE",628000,"Upper middle income","June 21, 2021",498,NaN,NaN,918,0.43,95.362,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.43 %","95.4 per 100k persons"
"Montserrat","MSR",NaN,"No income data","No tests reported",NaN,NaN,NaN,28,0.95,294.584,"Insufficient testing data","Meets sequencing target",NaN,"Insufficient data",NaN,"Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","0.95 %","294.6 per 100k persons"
"Morocco","MAR",36911000,"Lower middle income","October 31, 2022",1,0.0903,0.26,1415,0.3,2.563,"Does not meet testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","9 %","0.26 per 1,000 persons","0.3 %","2.6 per 100k persons"
"Mozambique","MOZ",31255000,"Low income","October 31, 2022",1,0.1717,0.04,1332,0.47,1.119,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","17.2 %","0.04 per 1,000 persons","0.47 %","1.1 per 100k persons"
"Myanmar","MMR",54410000,"Lower middle income","October 30, 2022",2,0.0291,0.23,106,0.05,0.111,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","2.9 %","0.23 per 1,000 persons","0.05 %","0.1 per 100k persons"
"Namibia","NAM",2541000,"Upper middle income","September 13, 2022",49,0.1223,0.41,768,1.42,23.373,"Does not meet testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","12.2 %","0.41 per 1,000 persons","1.42 %","23.4 per 100k persons"
"Nauru","NRU",NaN,"High income","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Nepal","NPL",29137000,"Lower middle income","October 31, 2022",1,0.122,0.15,3307,0.77,4.707,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","12.2 %","0.15 per 1,000 persons","0.77 %","4.7 per 100k persons"
"Netherlands","NLD",17135000,"High income","January 25, 2022",280,0.2196,6.02,144424,1.1,398.001,"Insufficient testing data","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","22 %","6.02 per 1,000 persons","1.1 %","398 per 100k persons"
"New Caledonia","NCL",285000,"High income","September 07, 2021",420,NaN,NaN,9,0.01,3.104,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.01 %","3.1 per 100k persons"
"New Zealand","NZL",4822000,"High income","October 31, 2022",1,0.5169,2.02,24116,1.1,392.36,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","51.7 %","2.02 per 1,000 persons","1.1 %","392.4 per 100k persons"
"Nicaragua","NIC",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,867,8.22,2.72,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","8.22 %","2.7 per 100k persons"
"Niger","NER",24207000,"Low income","October 31, 2022",1,0.0254,0.01,343,4.35,0.507,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","2.5 %","0.01 per 1,000 persons","4.35 %","0.5 per 100k persons"
"Nigeria","NGA",206140000,"Lower middle income","October 16, 2022",16,0.0238,0.03,7308,6.13,1.517,"Does not meet testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","2.4 %","0.03 per 1,000 persons","6.13 %","1.5 per 100k persons"
"Niue","NIU",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Norfolk Island","NFK",NaN,"No income data","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"North Korea","PRK",NaN,"Low income","No tests reported",NaN,NaN,NaN,0,0,NaN,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","Insufficient data"
"North Macedonia","MKD",2083000,"Upper middle income","February 24, 2022",250,0.1966,1.94,924,0.15,10.269,"Insufficient testing data","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","19.7 %","1.94 per 1,000 persons","0.15 %","10.3 per 100k persons"
"Northern Mariana Islands","MNP",NaN,"High income","No tests reported",NaN,NaN,NaN,3380,NaN,NaN,"Insufficient testing data","Insufficient data",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Norway","NOR",5421000,"High income","October 30, 2022",2,0.3896,1.63,72882,3.01,695.431,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","39 %","1.63 per 1,000 persons","3.01 %","695.4 per 100k persons"
"Oman","OMN",5107000,"High income","May 28, 2021",522,NaN,NaN,917,0.11,2.207,"Insufficient testing data","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","Insufficient data","Insufficient data","0.11 %","2.2 per 100k persons"
"Pakistan","PAK",220892000,"Lower middle income","October 28, 2022",4,0.03,0.13,5562,0.86,1.098,"Does not meet testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","3 %","0.13 per 1,000 persons","0.86 %","1.1 per 100k persons"
"Palau","PLW",NaN,"High income","No tests reported",NaN,NaN,NaN,47,0.64,193.541,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","0.64 %","193.5 per 100k persons"
"Palestine","PSE",5101000,"Lower middle income","February 03, 2022",271,0.2125,0.9,129,0,0.019,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","21.2 %","0.9 per 1,000 persons","0 %","0 per 100k persons"
"Panama","PAN",4315000,"High income","October 15, 2022",17,0.1684,2.02,6110,0.57,67.096,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","16.8 %","2.02 per 1,000 persons","0.57 %","67.1 per 100k persons"
"Papua New Guinea","PNG",8947000,"Lower middle income","November 28, 2021",338,0.1533,0.15,4382,4.87,7.523,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Sustain","no","15.3 %","0.15 per 1,000 persons","4.87 %","7.5 per 100k persons"
"Paraguay","PRY",7133000,"Upper middle income","March 27, 2022",219,0.2622,0.67,2743,0.66,24.968,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Connect/Build","no","26.2 %","0.67 per 1,000 persons","0.66 %","25 per 100k persons"
"Peru","PER",32972000,"Upper middle income","October 24, 2022",8,0.1181,1.4,34980,1.17,67.099,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","11.8 %","1.4 per 1,000 persons","1.17 %","67.1 per 100k persons"
"Philippines","PHL",109581000,"Lower middle income","October 30, 2022",2,0.1185,0.26,22470,0.75,7.859,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","11.8 %","0.26 per 1,000 persons","0.75 %","7.9 per 100k persons"
"Pitcairn Islands","PCN",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Poland","POL",37847000,"High income","October 19, 2022",13,0.2156,1.15,88223,1.79,148.493,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","21.6 %","1.15 per 1,000 persons","1.79 %","148.5 per 100k persons"
"Portugal","PRT",10197000,"High income","June 02, 2022",152,0.1581,10.45,42998,0.5,214.782,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","15.8 %","10.45 per 1,000 persons","0.5 %","214.8 per 100k persons"
"Puerto Rico","PRI",NaN,"High income","No tests reported",NaN,NaN,NaN,15594,NaN,NaN,"Insufficient testing data","Insufficient data",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Qatar","QAT",2881000,"High income","October 31, 2022",1,0.1889,1.15,5049,0.36,30.833,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","18.9 %","1.15 per 1,000 persons","0.36 %","30.8 per 100k persons"
"Republic of the Congo","COG",5518000,"Lower middle income","July 04, 2022",120,0.0401,0.13,617,2.26,2.713,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","4 %","0.13 per 1,000 persons","2.26 %","2.7 per 100k persons"
"Romania","ROU",19238000,"High income","June 27, 2022",127,0.1475,1.89,18672,0.64,52.713,"Meets testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","14.8 %","1.89 per 1,000 persons","0.64 %","52.7 per 100k persons"
"Russia","RUS",145934000,"Upper middle income","October 23, 2022",9,0.1185,2.06,34635,0.17,14.841,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","11.8 %","2.06 per 1,000 persons","0.17 %","14.8 per 100k persons"
"Rwanda","RWA",12952000,"Low income","October 07, 2022",25,0.0121,0.61,786,0.27,0.639,"Meets testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Sustain","Connect/Build","Sustain - Sustain diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Sustain","Connect/Build","no","1.2 %","0.61 per 1,000 persons","0.27 %","0.6 per 100k persons"
"Saint Helena","SHN",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",NaN,"Insufficient data",NaN,"Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Saint Kitts and Nevis","KNA",53000,"High income","October 28, 2022",4,0.0465,4.33,74,0.77,62.918,"Meets testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","4.7 %","4.33 per 1,000 persons","0.77 %","62.9 per 100k persons"
"Saint Lucia","LCA",184000,"Upper middle income","October 08, 2022",24,0.1351,1.99,239,0.83,78.389,"Meets testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","13.5 %","1.99 per 1,000 persons","0.83 %","78.4 per 100k persons"
"Saint Martin","MAF",NaN,"High income","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Saint Pierre and Miquelon","SPM",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",NaN,"Insufficient data",NaN,"Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Saint Vincent and the Grenadines","VCT",111000,"Upper middle income","August 28, 2022",65,0.2032,0.9,222,2.18,126.011,"Does not meet testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","20.3 %","0.9 per 1,000 persons","2.18 %","126 per 100k persons"
"Saint-Barth√©lemy","BLM",NaN,"No income data","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Samoa","WSM",NaN,"Upper middle income","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"San Marino","SMR",34000,"High income","October 31, 2022",1,0.1794,7.21,0,0,0,"Meets testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Sustain","Connect/Build","Sustain - Sustain diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Sustain","Connect/Build","no","17.9 %","7.21 per 1,000 persons","0 %","0 per 100k persons"
"S√£o Tom√© and Pr√≠ncipe","STP",219000,"Lower middle income","October 31, 2022",1,0.1139,0.28,11,0.04,0.44,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","11.4 %","0.28 per 1,000 persons","0.04 %","0.4 per 100k persons"
"Saudi Arabia","SAU",34814000,"High income","October 31, 2022",1,0.0191,1.13,1252,0.02,0.121,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","1.9 %","1.13 per 1,000 persons","0.02 %","0.1 per 100k persons"
"Senegal","SEN",16744000,"Lower middle income","October 31, 2022",1,0.0342,0.07,5833,12.82,10.926,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","3.4 %","0.07 per 1,000 persons","12.82 %","10.9 per 100k persons"
"Serbia","SRB",8737000,"Upper middle income","October 31, 2022",1,0.2503,1.59,1912,0.1,19.05,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","25 %","1.59 per 1,000 persons","0.1 %","19 per 100k persons"
"Seychelles","SYC",98000,"High income","December 21, 2020",680,NaN,NaN,1484,3.51,876.464,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","3.51 %","876.5 per 100k persons"
"Sierra Leone","SLE",7977000,"Low income","September 15, 2022",47,0.0067,0.08,126,0.15,0.023,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","0.7 %","0.08 per 1,000 persons","0.15 %","0 per 100k persons"
"Singapore","SGP",5850000,"High income","October 25, 2022",7,0.0465,19.18,25596,0.86,289.053,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","4.7 %","19.18 per 1,000 persons","0.86 %","289.1 per 100k persons"
"Sint Maarten (Dutch part)","SXM",NaN,"High income","No tests reported",NaN,NaN,NaN,2649,NaN,NaN,"Insufficient testing data","Insufficient data",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Slovakia","SVK",5460000,"High income","October 30, 2022",2,0.2109,4.19,44068,1.78,549.805,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","yes","21.1 %","4.19 per 1,000 persons","1.78 %","549.8 per 100k persons"
"Slovenia","SVN",2079000,"High income","October 31, 2022",1,0.0824,14.42,77492,4.32,1828.249,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","8.2 %","14.42 per 1,000 persons","4.32 %","1828.2 per 100k persons"
"Solomon Islands","SLB",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,246,1.1,32.584,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","1.1 %","32.6 per 100k persons"
"Somalia","SOM",15893000,"Low income","July 05, 2022",119,0.0263,0.05,45,0.06,0.017,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","2.6 %","0.05 per 1,000 persons","0.06 %","0 per 100k persons"
"South Africa","ZAF",59309000,"Upper middle income","October 14, 2022",18,0.1429,0.37,47026,1.91,34.75,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","14.3 %","0.37 per 1,000 persons","1.91 %","34.8 per 100k persons"
"South Georgia and the South Sandwich Islands","SGS",NaN,"No income data","No tests reported",NaN,NaN,NaN,NaN,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"South Korea","KOR",51269000,"High income","October 31, 2021",366,0.0467,0.87,94924,0.27,132.348,"Insufficient testing data","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","4.7 %","0.87 per 1,000 persons","0.27 %","132.3 per 100k persons"
"South Sudan","SSD",11194000,"Low income","July 17, 2022",107,0.0307,0.06,170,0.63,0.312,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","3.1 %","0.06 per 1,000 persons","0.63 %","0.3 per 100k persons"
"Spain","ESP",46755000,"High income","October 31, 2022",1,0.2375,2.1,164616,1,178.563,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","23.8 %","2.1 per 1,000 persons","1 %","178.6 per 100k persons"
"Sri Lanka","LKA",21413000,"Lower middle income","June 16, 2022",138,0.0745,0.34,3532,1.34,7.938,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","7.4 %","0.34 per 1,000 persons","1.34 %","7.9 per 100k persons"
"Sudan","SDN",43849000,"Low income","October 27, 2021",370,NaN,NaN,347,0.58,0.286,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.58 %","0.3 per 100k persons"
"Suriname","SUR",NaN,"Upper middle income","No tests reported",NaN,NaN,NaN,1116,0.77,40.126,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","0.77 %","40.1 per 100k persons"
"Sweden","SWE",10099000,"High income","May 10, 2021",540,NaN,NaN,219412,6.47,882.671,"Insufficient testing data","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","6.47 %","882.7 per 100k persons"
"Switzerland","CHE",8655000,"High income","October 25, 2022",7,0.291,3.68,152303,2.07,792.658,"Does not meet testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","29.1 %","3.68 per 1,000 persons","2.07 %","792.7 per 100k persons"
"Syria","SYR",NaN,"Low income","No tests reported",NaN,NaN,NaN,106,0.77,0.479,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.77 %","0.5 per 100k persons"
"Taiwan","TWN",23817000,"High income","November 01, 2022",0,0.3779,2.33,2520,0.03,8.927,"Does not meet testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","37.8 %","2.33 per 1,000 persons","0.03 %","8.9 per 100k persons"
"Tajikistan","TJK",9538000,"Low income","March 30, 2020",946,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Tanzania","TZA",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,2,0.01,0.003,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0.01 %","0 per 100k persons"
"Thailand","THA",69800000,"Upper middle income","October 26, 2022",6,0.2673,0.42,28206,0.68,26.295,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","26.7 %","0.42 per 1,000 persons","0.68 %","26.3 per 100k persons"
"The Bahamas","BHS",393000,"High income","October 26, 2022",6,0.1518,0.7,263,0.25,9.269,"Meets testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Sustain","Connect/Build","Sustain - Sustain diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Sustain","Connect/Build","no","15.2 %","0.7 per 1,000 persons","0.25 %","9.3 per 100k persons"
"The Gambia","GMB",2417000,"Low income","October 02, 2022",30,0.042,0.07,1415,13.24,12.786,"Does not meet testing target","Meets sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","4.2 %","0.07 per 1,000 persons","13.24 %","12.8 per 100k persons"
"Togo","TGO",8279000,"Low income","October 31, 2022",1,0.0527,0.08,811,1.85,2.757,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","5.3 %","0.08 per 1,000 persons","1.85 %","2.8 per 100k persons"
"Tonga","TON",NaN,"Upper middle income","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Trinidad and Tobago","TTO",1399000,"High income","September 21, 2022",41,0.3029,0.91,4072,1.87,155.841,"Does not meet testing target","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Test","Sustain","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels","Test","Sustain","yes","30.3 %","0.91 per 1,000 persons","1.87 %","155.8 per 100k persons"
"Tunisia","TUN",11819000,"Lower middle income","October 31, 2022",1,0.2288,0.44,1444,0.09,3.108,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","22.9 %","0.44 per 1,000 persons","0.09 %","3.1 per 100k persons"
"Turkey","TUR",84339000,"Upper middle income","October 31, 2022",1,0.1592,1.82,98231,0.33,33.865,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","15.9 %","1.82 per 1,000 persons","0.33 %","33.9 per 100k persons"
"Turkmenistan","TKM",NaN,"Upper middle income","No tests reported",NaN,NaN,NaN,0,NaN,NaN,"Insufficient testing data","Insufficient data",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Turks and Caicos Islands","TCA",NaN,"High income","No tests reported",NaN,NaN,NaN,72,0.75,56.86,"Insufficient testing data","Meets sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Strengthen","Insufficient data","Sustain","Insufficient testing data","Sustain - Sustain current sequencing levels","Insufficient data","Sustain","no","Insufficient data","Insufficient data","0.75 %","56.9 per 100k persons"
"Tuvalu","TUV",NaN,"Upper middle income","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"U.S. Virgin Islands","VIR",NaN,"High income","No tests reported",NaN,NaN,NaN,2313,NaN,NaN,"Insufficient testing data","Insufficient data",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Uganda","UGA",45741000,"Low income","October 07, 2022",25,0.0373,0.07,1287,0.8,0.73,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","3.7 %","0.07 per 1,000 persons","0.8 %","0.7 per 100k persons"
"Ukraine","UKR",43734000,"Lower middle income","June 15, 2022",139,0.4341,0.52,1316,0.03,2.055,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","43.4 %","0.52 per 1,000 persons","0.03 %","2.1 per 100k persons"
"United Arab Emirates","ARE",9890000,"High income","June 30, 2022",124,0.0027,32.11,2615,0,0.011,"Meets testing target","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Sustain","Strengthen/Leverage","Sustain - Sustain diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Sustain","Strengthen/Leverage","no","0.3 %","32.11 per 1,000 persons","0 %","0 per 100k persons"
"United Kingdom","GBR",67886000,"High income","May 23, 2022",162,0.0717,13.38,2842479,11.72,2423.184,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","7.2 %","13.38 per 1,000 persons","11.72 %","2423.2 per 100k persons"
"United States Minor Outlying Islands","UMI",NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN,NaN
"United States of America","USA",331003000,"High income","September 21, 2022",41,0.1355,3.4,4189250,4.47,678.571,"Meets testing target","Meets sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Strengthen","Sustain","Sustain","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels","Sustain","Sustain","no","13.6 %","3.4 per 1,000 persons","4.47 %","678.6 per 100k persons"
"Uruguay","URY",3474000,"High income","April 18, 2022",197,0.2207,3.83,942,0.01,1.695,"Insufficient testing data","Does not meet sequencing target",2,"Has access to sequencing facilities","4+ NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","22.1 %","3.83 per 1,000 persons","0.01 %","1.7 per 100k persons"
"Uzbekistan","UZB",33469000,"Lower middle income","July 14, 2020",840,NaN,NaN,90,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Vanuatu","VUT",NaN,"Lower middle income","No tests reported",NaN,NaN,NaN,1,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Vatican City","VAT",NaN,"No income data","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",NaN,"Insufficient data",NaN,"Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Venezuela","VEN",28436000,"Upper middle income","May 30, 2021",520,NaN,NaN,813,0.2,0.975,"Insufficient testing data","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","Insufficient data","Insufficient data","0.2 %","1 per 100k persons"
"Vietnam","VNM",97339000,"Lower middle income","May 08, 2021",542,NaN,NaN,6598,0.05,4.959,"Insufficient testing data","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Insufficient data","Strengthen/Leverage","Insufficient testing data","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Insufficient data","Strengthen/Leverage","no","Insufficient data","Insufficient data","0.05 %","5 per 100k persons"
"Wallis and Futuna","WLF",NaN,"No income data","No tests reported",NaN,NaN,NaN,10,0,0,"Insufficient testing data","Does not meet sequencing target",NaN,"Insufficient data",NaN,"Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"West Bank and Gaza","PSE",5101000,"Lower middle income","February 03, 2022",271,0.2125,0.9,129,0,0.019,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","21.2 %","0.9 per 1,000 persons","0 %","0 per 100k persons"
"Western Sahara","ESH",597000,"No income data","October 13, 2021",384,NaN,NaN,0,NaN,NaN,"Insufficient testing data","Insufficient data",NaN,"Insufficient data",NaN,"Insufficient data","Insufficient data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics","Insufficient data","Insufficient data","no","Insufficient data","Insufficient data","Insufficient data","Insufficient data"
"Yemen","YEM",NaN,"Low income","No tests reported",NaN,NaN,NaN,0,0,0,"Insufficient testing data","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Insufficient data","Connect/Build","Insufficient testing data","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Insufficient data","Connect/Build","no","Insufficient data","Insufficient data","0 %","0 per 100k persons"
"Zambia","ZMB",18384000,"Lower middle income","October 31, 2022",1,0.1073,0.17,1547,0.35,2.153,"Does not meet testing target","Does not meet sequencing target",1,"Has access to sequencing facilities","1-3 NGS facilities or equivalent","Leverage","Test","Strengthen/Leverage","Test - Increase diagnostic testing capacity","Strengthen / Leverage - Strengthen sequencing levels by leveraging existing NGS capacity","Test","Strengthen/Leverage","no","10.7 %","0.17 per 1,000 persons","0.35 %","2.2 per 100k persons"
"Zimbabwe","ZWE",14863000,"Lower middle income","October 31, 2022",1,0.1208,0.19,959,0.2,1.526,"Does not meet testing target","Does not meet sequencing target",0,"Does not have access to sequencing facilities","0 NGS facilities or equivalent","Connect","Test","Connect/Build","Test - Increase diagnostic testing capacity","Connect / Build - Connect to countries with NGS capacity or build NGS capacity from scratch","Test","Connect/Build","no","12.1 %","0.19 per 1,000 persons","0.2 %","1.5 per 100k persons"
